Literature DB >> 20851414

Impact of complications after surgery for colorectal liver metastasis on patient survival.

Abbey Schepers1, Sven Mieog, Boudewijn Borger van de Burg, Jan van Schaik, Gerrit-Jan Liefers, Perla J Marang-van de Mheen.   

Abstract

BACKGROUND: In some patients with colorectal liver metastases it is not clear whether liver resection or isolated liver perfusion is the best treatment option. For instance, the risk of complications after surgery may be so substantial and affect subsequent survival. Aim of the present study is to compare complication occurrence and its effect on survival after liver resection and perfusion.
METHODS: Patient records of all 225 patients with colorectal liver metastases treated with liver resection (n = 121) or liver perfusion (n = 104) in the period 1997-2006 were reviewed for complications during the initial hospitalisation until 30 d after discharge, and to assess patient survival until the last hospital visit. Median duration of follow-up was 38 mo for overall survival and 22 mo for survival after surgery.
RESULTS: Complications occurred less often in patients undergoing resection than perfusion (29.8% versus 49.0%, X(2) = 8.77, P < 0.01). Postoperative mortality rates were similar in both groups (4.1% and 4.8%, respectively). As expected, long term survival after liver surgery was better in the resection group: at 3 y, 60% of patients survived in the resection group, compared with 22% after liver perfusion (log rank X(2) = 35.29 P < 0.001). However, liver resection patients with postoperative complications, had similar survival as perfusion patients without complications (log rank X(2) = 2.45, p = 0.12). This remained after adjustment for differences between the patient groups at time of surgery.
CONCLUSION: Liver resection has superior long-term survival, but survival is significantly reduced by the occurrence of post-surgical complications. When complications occur after liver resection, survival is comparable to patients who underwent uncomplicated liver perfusion.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20851414     DOI: 10.1016/j.jss.2010.07.022

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Effects of postoperative morbidity on long-term outcome following surgery for colorectal liver metastases.

Authors:  T M Lodewick; M C de Jong; R M van Dam; M H A Bemelmans; U P Neumann; S W M Olde Damink; C H C Dejong
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

2.  Impact of preoperative targeted therapy on postoperative complications after resection of colorectal liver metastases.

Authors:  Hannes P Neeff; Oliver Drognitz; Andrea Klock; Gerald Illerhaus; Oliver G Opitz; Ulrich T Hopt; Frank Makowiec
Journal:  Int J Colorectal Dis       Date:  2011-12-06       Impact factor: 2.571

3.  Radiofrequency ablation of metastatic lesions from breast cancer.

Authors:  C Bortolotto; S Macchi; L Veronese; R Dore; F Draghi; S Rossi
Journal:  J Ultrasound       Date:  2012-06-27

4.  Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).

Authors:  Christos Dervenis; Evaghelos Xynos; George Sotiropoulos; Nikolaos Gouvas; Ioannis Boukovinas; Christos Agalianos; Nikolaos Androulakis; Athanasios Athanasiadis; Christos Christodoulou; Evangelia Chrysou; Christos Emmanouilidis; Panagiotis Georgiou; Niki Karachaliou; Ourania Katopodi; Panteleimon Kountourakis; Ioannis Kyriazanos; Thomas Makatsoris; Pavlos Papakostas; Demetris Papamichael; George Pechlivanides; Georgios Pentheroudakis; Ioannis Pilpilidis; Joseph Sgouros; Paris Tekkis; Charina Triantopoulou; Maria Tzardi; Vassilis Vassiliou; Louiza Vini; Spyridon Xynogalos; Nikolaos Ziras; John Souglakos
Journal:  Ann Gastroenterol       Date:  2016-06-03

5.  Synchronous Colorectal Liver Metastases considering Infectious Complications: Simultaneous or Delayed Surgery?

Authors:  Lijun Huang; Xiao Tang; Jiafeng Fang; Zongheng Zheng; Hongbo Wei
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-11       Impact factor: 2.650

6.  The Preoperative Assessment of Hepatic Tumours: Evaluation of UK Regional Multidisciplinary Team Performance.

Authors:  M G Wiggans; S A Jackson; B M T Fox; J D Mitchell; S Aroori; M J Bowles; E M Armstrong; J F Shirley; D A Stell
Journal:  HPB Surg       Date:  2013-08-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.